Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related CVS
3 Ways Amazon Could Transform Health Care
Trump Strikes At PBMs, Insurers, Drugmakers With Plans To Lower Consumer Prices
Goldman Sachs: Hedge funds betting against Nvidia, Intel (Seeking Alpha)
Related AGU
Wall Street's M&A Chatter From December 12: Fox-Disney, Repros Therapeutics-Allergan, Agrium-Macrofertil
Earnings Scheduled For November 7, 2017

Analysts at Goldman Sachs downgraded CVS (NYSE: CVS) from “buy” to “neutral.” The target price for CVS is set to $57. CVS's shares closed at $22.00 yesterday.

Analysts at BMO Capital downgraded Agrium (NYSE: AGU) from “outperform” to “market perform.” The target price for Agrium is set to $120. Agrium's shares closed at $107.21 yesterday.

Analysts at Citigroup downgraded Red Hat (NYSE: RHT) from “buy” to “neutral.” The target price for Red Hat has been lowered from $64 to $56. Red Hat's shares closed at $53.14 yesterday.

DA Davidson downgraded Cadence Design Systems (NASDAQ: CDNS) from “buy” to “neutral.” The target price for Cadence Design Systems has been lowered from $27 to $15. Cadence Design Systems' shares closed at $14.58 yesterday.

Latest Ratings for CVS

Apr 2018Bank of AmericaMaintainsBuyBuy
Feb 2018CitigroupMaintainsNeutralNeutral
Feb 2018Leerink SwannMaintainsOutperformOutperform

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (AGU + BZSUM)

View Comments and Join the Discussion!